Simultaneous knockdown of PPARγ and ASAH1 inhibited the ability of C2 ceramide or rosiglitazone to activate PPAR-responsive firefly-luciferase reporter activity in melanoma cells (Figure 5I). The gene discussed is PPARG; the disease is melanoma.